Seoul
South Korea
4
2021-06-03
3
2022-11-29
These are the the leading inventors for applications assigned to CYTOGEN, INC.:
CYTOGEN, INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Prostate-specific membrane antigen-based prostate cancer patient screening method
#2 | 2020-07-16 ✅ Patent 11,789,023 granted on 2023-10-17Androgen receptor variant-based prostate cancer patient screening method
#3 | 2020-06-25AXL-BASED CANCER PATIENT SCREENING METHOD
#4 | 2020-05-07 ✅ Patent 11,718,882 granted on 2023-08-08EML4-ALK gene mutation analysis method
Also check out CYTOGEN, INC.'s (Seoul, South Korea) applicant profile with 4 patent applications submitted.
157965 ⎘